We are currently carrying out work to improve the usability of our search function. This may cause search results to be incomplete. We anticipate this issue will be resolved in the coming hours. To fetch data from this website via automated systems, please use our JSON data files.
Filter by
Past events (2972)
European Medicines Agency, Amsterdam, the Netherlands
Start date:
12 February 2024, 09:00 (CET)
End date:
15 February 2024, 13:30 (CET)
Event
Human
Clinical trials
European Medicines Agency, Amsterdam, the Netherlands
Start date:
12 February 2024
End date:
13 February 2024
Event
Human
Corporate
Medicines
Online
European Medicines Agency, Amsterdam, the Netherlands
Live broadcast
Start date:
9 February 2024, 10:00 (CET)
End date:
9 February 2024, 13:00 (CET)
Event
Human
Clinical trials
EMA and EFPIA met in the context of EMA's annual bilateral meetings with industry stakeholder organisations
European Medicines Agency, Amsterdam, the Netherlands
Start date:
6 February 2024
End date:
6 February 2024
Event
Human
Medicines
The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.
European Medicines Agency, Amsterdam, the Netherlands
Start date:
5 February 2024
End date:
8 February 2024
Event
Human
Pharmacovigilance
European Medicines Agency, Amsterdam, the Netherlands
Start date:
1 February 2024, 15:30 (CET)
End date:
1 February 2024, 17:00 (CET)
Event
Human
Medicines
Online
Start date:
29 January 2024
End date:
29 January 2024
Event
Human
Medicines
European Medicines Agency, Amsterdam, the Netherlands
Start date:
29 January 2024
End date:
29 January 2024
Event
Human
Veterinary
Medicine shortages
European Medicines Agency, Amsterdam, the Netherlands
Start date:
29 January 2024
End date:
31 January 2024
Event
Herbal
Medicines
EudraVigilance is the EU's system for managing and analysing information on adverse reactions to medicines which have been authorised or are being studied in clinical trials in the European Economic Area (EEA) and supports the reporting and analysis of suspected adverse reactions originating from clinical trials and the post-authorisation phase of...
Online
Start date:
29 January 2024
End date:
2 February 2024
Event